Patients undergoing resection of Merkel cell carcinoma have improved distant metastasis-free survival with adjuvant pembrolizumab — but any benefits for overall survival remain to be seen.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-adjuvant-pembrolizumab-boost-outcomes-resectable-merkel-2026a1000dy8?src=rss
Author :
Publish date : 2026-04-30 18:45:00
Copyright for syndicated content belongs to the linked Source.
